| SoCalBio Profile: Prism VentureWorks
Well-Regarded VC Fund Bets on Greater Los Angeles
 By Ahmed Enany, Editor-in-Chief &
Erik Deutsch, Managing Editor
Observers of the Los Angeles life-science scene have long noticed an imbalance: lots
of innovative ideas, but not enough smart money to
shepherd those ideas to commercial success.
This
situation seems counterintuitive, given the high regard
for the L.A.
region’s scientific infrastructure and its abundant
supply of innovative ideas. After all, the first biotech
drug, genetically-engineered insulin, was the result of
work done by Dr. Arthur Riggs and his colleagues at the City of Hope. Also, one of the most important scientific instruments
used in genetic research ...
Click
here to continue
|
USC/Harvard Researchers Identify Genetic Risk Factors for Prostate
Cancer
Discovery Could Facilitate Early Diagnostics and Pave
the Way for Targeted Therapies
 By
MaryAnn Foote, Ph.D.
M A Foote Associates
In April, researchers at USC’s Keck School of Medicine
and
Harvard
Medical
School
reported in the journal Nature Genetics that they
have identified genetic risk factors that independently
and in combination predict the occurrence of prostate
cancer.
The
study focused on seven DNA sequences clustered in a
single region of the human genome on chromosome 8 ...Click
here to continue
|
| Leadership
Style Counts in the Biomed Industry
By David Jensen, CareerTrax Inc.
Dale Carnegie, whose self-help empire was
built on the premise that dealing with people is man’s most difficult
challenge, once said "Even in such technical lines as science and
engineering, only about 15% of a person’s financial and career success
is due to technical knowledge, the other 85% is due to skill in human
engineering and the ability to lead people."
Whether you are a bench scientist or
already on the management track at your company, developing the skills
to lead people should be a part of your career plan. It’s not just the
boss who needs to be up-to-date on leadership skills. As a consultant, I
often see examples of technical people who are denied that move up the
ladder . . Click
here to continue
|
Caltech
Chips Could Transform Medical Electronics
 By Ahmed Enany,
Editor-in-Chief
The
goal of etching high performance electronic
circuits
using standard silicon-based techniques
on a piece of flexible plastic has eluded researchers
for quite some time. This is because silicon chips
require processing temperatures high enough to melt any
plastic base holding the silicon crystals in place. But,
thanks to pioneering research on nanowires at Caltech,
the goal of producing complex silicon circuits on
flexible plastic substrates is now within reach.
A paper
recently published in Nature Materials(1) by
the James Heath Research Group at Caltech describes a
method for .......Click
here to continue |
|
SoCalBio
Roundup
The Latest
from SoCalBio Device and Biotech Companies
By Ahmed Enany,
Editor-in-Chief
-
New NIH SBIR Grants
(ArmaGen,
Echemics, Neurion, Immport Therapeutics, Intelligent
Optical Systems, NeuroSystec)
-
Clinical Studies (Edwards
Lifesciences, Second Sight)
-
Recent Private
Equity Deals (AccuFocus, C3 Scientific,
ChimeraCore, CoreValve, CytRx, Gevo, Glaukos, Inogen,
Novocell, Numira Biosciences, Orqis Medical,
ReVision Optics, Visiogen)
-
SoCalBio Group
Purchasing Program
-
Collaborations (Precision Dynamics Corp.,
Agensys, Obagi Medical Products, Xencor, Biosense Webster,
Abraxis Bioscience)
-
IPOs (Masimo,
Devax, SenoRx)
-
Medical Device
Clearance
-
Featured 510(K):
CamSight Click
here to continue
|
The Southern California Biomedical Council (SoCalBio) has announced that Leroy Hood, Ph.D.,
of the Seattle-based Institute for Systems Biology, and George Bekey, Ph.D., of USC, will keynote the 9th SoCalBio Investor Conference.
This annual event -- which showcases emerging L.A. region life-science technologies and companies -- will be held June 7, 2007 at the Wilshire Grand Hotel in downtown Los Angeles.
Dr. Hood will deliver the luncheon
keynote speech focusing on new directions in medicine based on systems
approaches to biology. Dr. Bekey will keynote the CEO/Investor dinner
and discuss future applications of robotics in medicine ...Click
here to continue |
Dr.
Hood of the Institute for Systems Biology in Seattle, WA |
